Low BMI Is a Predictor of Death for TAVI

Courtesy of Dr. Carlos Fava.

 

low BMI death TAVI

 

Body mass index (BMI) has always played an important role in heart surgery. However, there is little evidence on BMI effects on TAVI.

This study included 491 patients, which were divided according to BMI into:

 

  • low (<20 Kg/m2 )
  • normal (20-24.9 Kg/m2 )
  • overweight (25-30 Kg/m2 )
  • obese (>30 Kg/m2 )

 

BMI was low in 43 patients (8.7%), normal in 148 (30.1%), overweight in 162 (33%) and obese in 138 (28.1%).

Obese patients were younger, diabetes was more frequent among morbid obese, but there were fewer with prior MI.

STS score was inversely associated with BMI:

Low weight: 11.4±4.9

Normal: 9.1±4.8

Overweight: 8.4±4.3

Obesity: 7.9±4

[p<0.001]

Ejection fraction was also inversely associated to BMI, but the opposite happened with the aortic valve area.

There was no difference in procedural success, except for longer fluoroscopy time in the group with morbid obesity. Vascular complications and transfusions (VARC-2 criteria) were higher in the low BMI group, while acute kidney injury was higher in the highest BMI group.

At one year follow up, all-cause mortality was higher in the low BMI group compared to the other 3 groups (p=0.003).

In multivariable analyzis, BMI <20 Kg/mwas an independent predictor of mortality (HR=2.45; p=0.01).

 

Conclusion

Body mass index <20 Kg/mshould be considered a fragility marker during screening for TAVI of patients with severe aortic stenosis, since it is associated to high mortality, while obese patients presented similar mortality risk to those of normal weight.

 

Editorial Comment

BMI should be included as part of patient screening routine procedures when considering TAVI, because it is associated with in-hospital complications and mortality. BMI could be used as a sign of fragility. We should controlling fluid balance in morbid obesity because these patients present higher kidney failure rate after implantation, which can be associated to loss of volume, hard to recover immediately after procedure.

 

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

 

Original Title: Body Mass Index Association with Survival in Severe Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Replacement

Reference: Edward Koifman, et al. Cateheterization cardiovascular Intervention 2016;88:118-124

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or suggestions here below.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....